PMC:7346000 / 22502-22757
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 670 | 218-230 | Chemical | denotes | voriconazole | MESH:D065819 |
| 694 | 140-154 | Disease | denotes | hepatotoxicity | MESH:D056486 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T136 | 83-87 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T137 | 161-165 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T138 | 166-170 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T139 | 218-230 | Chemical | denotes | voriconazole | http://purl.obolibrary.org/obo/CHEBI_10023 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T120 | 0-255 | Sentence | denotes | However, besides its narrow therapeutic window and the requirement for therapeutic drug monitoring to ensure efficacy and prevent neuro and hepatotoxicity [81], drug–drug interactions may particularly limit the use of voriconazole in the ICU setting [82]. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32599813-23629724-60095148 | 156-158 | 23629724 | denotes | 81 |
| 32599813-30816967-60095149 | 251-253 | 30816967 | denotes | 82 |